US Stock MarketDetailed Quotes

Bone Biologics (BBLG)

Watchlist
  • 1.760
  • +0.040+2.33%
Close Jan 22 16:00 ET
  • 1.760
  • 0.0000.00%
Post 16:04 ET
3.16MMarket Cap-0.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bone Biologics (BBLG) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
69.61%6.05M
184.75%6.64M
-14.91%2.75M
9.86%3.33M
9.86%3.33M
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
-Cash and cash equivalents
69.61%6.05M
184.75%6.64M
-14.91%2.75M
9.86%3.33M
9.86%3.33M
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
Prepaid assets
-39.58%301.72K
-58.00%361.75K
-32.10%415.51K
-24.60%536.24K
-24.60%536.24K
-4.65%499.39K
40.01%861.4K
2.77%611.94K
-25.68%711.19K
-25.68%711.19K
Total current assets
56.20%6.35M
119.27%7M
-17.65%3.16M
3.31%3.86M
3.31%3.86M
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
-56.00%3.74M
-56.00%3.74M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
56.20%6.35M
119.27%7M
-17.65%3.16M
3.31%3.86M
3.31%3.86M
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
-56.00%3.74M
-56.00%3.74M
Liabilities
Current liabilities
Payables
75.25%333.08K
74.12%403.73K
69.54%247.84K
3.43%373.04K
3.43%373.04K
--190.06K
--231.87K
--146.19K
244.19%360.66K
244.19%360.66K
-accounts payable
75.25%333.08K
74.12%403.73K
69.54%247.84K
3.43%373.04K
3.43%373.04K
--190.06K
--231.87K
--146.19K
244.19%360.66K
244.19%360.66K
Current accrued expenses
----
----
----
--0
--0
--0
--0
----
--414.99K
--414.99K
Current deferred liabilities
----
----
----
--0
--0
--65.72K
--44.98K
----
--0
--0
Other current liabilities
-93.19%1.2K
-68.48%2.41K
-82.02%3.32K
-91.62%4.67K
-91.62%4.67K
-78.10%17.63K
-96.83%7.66K
-98.94%18.44K
-96.64%55.75K
-96.64%55.75K
Current liabilities
22.27%334.28K
42.75%406.14K
52.56%251.16K
-54.57%377.71K
-54.57%377.71K
-76.89%273.4K
-85.26%284.51K
-95.90%164.63K
-67.37%831.4K
-67.37%831.4K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
22.27%334.28K
42.75%406.14K
52.56%251.16K
-54.57%377.71K
-54.57%377.71K
-76.89%273.4K
-85.26%284.51K
-95.90%164.63K
-67.37%831.4K
-67.37%831.4K
Shareholders'equity
Share capital
-14.36%1.8K
28.14%1.69K
221.85%3.27K
453.00%2.95K
453.00%2.95K
-33.14%2.1K
-58.05%1.32K
-93.92%1.02K
734.38%534
734.38%534
-common stock
-14.36%1.8K
28.14%1.69K
221.85%3.27K
453.00%2.95K
453.00%2.95K
-33.14%2.1K
-58.05%1.32K
-93.92%1.02K
734.38%534
734.38%534
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-4.73%-87.45M
-5.11%-86.78M
-5.21%-86.04M
-5.08%-85.02M
-5.08%-85.02M
-5.22%-83.5M
-6.61%-82.56M
-8.07%-81.77M
-12.44%-80.91M
-12.44%-80.91M
Paid-in capital
7.07%93.46M
9.25%93.37M
4.09%88.95M
5.59%88.5M
5.59%88.5M
4.98%87.29M
2.81%85.47M
8.96%85.45M
7.58%83.81M
7.58%83.81M
Total stockholders'equity
58.65%6.02M
126.75%6.6M
-20.79%2.91M
19.86%3.48M
19.86%3.48M
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
-51.13%2.91M
-51.13%2.91M
Total equity
58.65%6.02M
126.75%6.6M
-20.79%2.91M
19.86%3.48M
19.86%3.48M
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
-51.13%2.91M
-51.13%2.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 69.61%6.05M184.75%6.64M-14.91%2.75M9.86%3.33M9.86%3.33M-19.90%3.57M-66.72%2.33M-47.84%3.23M-59.85%3.03M-59.85%3.03M
-Cash and cash equivalents 69.61%6.05M184.75%6.64M-14.91%2.75M9.86%3.33M9.86%3.33M-19.90%3.57M-66.72%2.33M-47.84%3.23M-59.85%3.03M-59.85%3.03M
Prepaid assets -39.58%301.72K-58.00%361.75K-32.10%415.51K-24.60%536.24K-24.60%536.24K-4.65%499.39K40.01%861.4K2.77%611.94K-25.68%711.19K-25.68%711.19K
Total current assets 56.20%6.35M119.27%7M-17.65%3.16M3.31%3.86M3.31%3.86M-18.30%4.07M-58.11%3.19M-43.40%3.84M-56.00%3.74M-56.00%3.74M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 56.20%6.35M119.27%7M-17.65%3.16M3.31%3.86M3.31%3.86M-18.30%4.07M-58.11%3.19M-43.40%3.84M-56.00%3.74M-56.00%3.74M
Liabilities
Current liabilities
Payables 75.25%333.08K74.12%403.73K69.54%247.84K3.43%373.04K3.43%373.04K--190.06K--231.87K--146.19K244.19%360.66K244.19%360.66K
-accounts payable 75.25%333.08K74.12%403.73K69.54%247.84K3.43%373.04K3.43%373.04K--190.06K--231.87K--146.19K244.19%360.66K244.19%360.66K
Current accrued expenses --------------0--0--0--0------414.99K--414.99K
Current deferred liabilities --------------0--0--65.72K--44.98K------0--0
Other current liabilities -93.19%1.2K-68.48%2.41K-82.02%3.32K-91.62%4.67K-91.62%4.67K-78.10%17.63K-96.83%7.66K-98.94%18.44K-96.64%55.75K-96.64%55.75K
Current liabilities 22.27%334.28K42.75%406.14K52.56%251.16K-54.57%377.71K-54.57%377.71K-76.89%273.4K-85.26%284.51K-95.90%164.63K-67.37%831.4K-67.37%831.4K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 22.27%334.28K42.75%406.14K52.56%251.16K-54.57%377.71K-54.57%377.71K-76.89%273.4K-85.26%284.51K-95.90%164.63K-67.37%831.4K-67.37%831.4K
Shareholders'equity
Share capital -14.36%1.8K28.14%1.69K221.85%3.27K453.00%2.95K453.00%2.95K-33.14%2.1K-58.05%1.32K-93.92%1.02K734.38%534734.38%534
-common stock -14.36%1.8K28.14%1.69K221.85%3.27K453.00%2.95K453.00%2.95K-33.14%2.1K-58.05%1.32K-93.92%1.02K734.38%534734.38%534
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -4.73%-87.45M-5.11%-86.78M-5.21%-86.04M-5.08%-85.02M-5.08%-85.02M-5.22%-83.5M-6.61%-82.56M-8.07%-81.77M-12.44%-80.91M-12.44%-80.91M
Paid-in capital 7.07%93.46M9.25%93.37M4.09%88.95M5.59%88.5M5.59%88.5M4.98%87.29M2.81%85.47M8.96%85.45M7.58%83.81M7.58%83.81M
Total stockholders'equity 58.65%6.02M126.75%6.6M-20.79%2.91M19.86%3.48M19.86%3.48M-0.02%3.79M-48.90%2.91M32.55%3.67M-51.13%2.91M-51.13%2.91M
Total equity 58.65%6.02M126.75%6.6M-20.79%2.91M19.86%3.48M19.86%3.48M-0.02%3.79M-48.90%2.91M32.55%3.67M-51.13%2.91M-51.13%2.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -